SCHEMBL10185708

SCHEMBL10185708

CCOC(=O)N1CCN(CC(=O)N(c2cccc(F)c2)C2C(=O)N(C3CCCCC3)c3ccccc32)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.41
▸ IDH1 O75874 3/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ OPRM1 P35372 2/20 0.39
▸ OPRK1 P41145 2/20 0.39
▸ OPRL1 P41146 2/20 0.39
▸ ALDH1A1 P00352 6/20 0.38
▸ KDM4E B2RXH2 4/20 0.38
▸ KMT2A Q03164 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CASP1 P29466 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183324 0.87 IDH1 (0.37) IDH1OPRM1OPRK1OPRL1ALDH1A1
SCHEMBL10185674 0.86 IDH1 (0.48) LMNAIDH1OPRM1OPRK1OPRL1
SCHEMBL10183330 0.86 IDH1 (0.48) LMNAIDH1OPRM1OPRK1OPRL1
SCHEMBL10184102 0.84 IDH1 (0.37) LMNAIDH1OPRM1OPRK1OPRL1
SCHEMBL10183317 0.83 OPRM1 (0.39) LMNAIDH1L3MBTL1OPRM1OPRK1
SCHEMBL10185557 0.83 OPRM1 (0.39) LMNAIDH1L3MBTL1OPRM1OPRK1
SCHEMBL10183299 0.82 OPRM1 (0.40) LMNAIDH1OPRM1OPRK1OPRL1
SCHEMBL10183319 0.81 MEN1 (0.43) LMNAIDH1OPRM1OPRK1OPRL1
SCHEMBL10183337 0.81 OPRM1 (0.39) LMNAIDH1OPRM1OPRK1OPRL1
SCHEMBL10183782 0.81 OPRM1 (0.40) LMNAIDH1OPRM1OPRK1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback